Cargando…

DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma

Glioblastomas are the most common primary central nervous system malignancy tumor in adults. Glioblastoma patients have poor prognosis, with an average survival period of approximately 14 mo after diagnosis. To date, there are a limited number of effective treatment methods for glioblastoma, and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yunliang, Qing, Cheng, Wang, Jiao, Zeng, Zhenguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563836/ https://www.ncbi.nlm.nih.gov/pubmed/32510239 http://dx.doi.org/10.1177/0963689720933241

Ejemplares similares

DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients
por: Wu, Zeng-hong, et al.
Publicado: (2020)

Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
por: Tang, Yunliang, et al.
Publicado: (2020)

Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers
por: Exner, Ruth, et al.
Publicado: (2015)

Predicting mortality in acute kidney injury patients undergoing continuous renal replacement therapy using a visualization model: A retrospective study
por: Zeng, Zhenguo, et al.
Publicado: (2022)

Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression
por: Mao, Yu Kun, et al.
Publicado: (2020)

Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation
por: Wang, Yilin, et al.
Publicado: (2020)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
por: Liouta, Galateia, et al.
Publicado: (2023)

Development of Potential Prognostic Biomarkers Based on DNA Methylation-Driven Genes for Patients with Endometrial Cancer
por: Lu, Yiling, et al.
Publicado: (2021)

Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer
por: Zhang, Ming, et al.
Publicado: (2020)

Deciphering a TB-related DNA methylation biomarker and constructing a TB diagnostic classifier
por: Lyu, Mengyuan, et al.
Publicado: (2021)

DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis
por: Wu, Na, et al.
Publicado: (2023)

Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma
por: Liu, Qiaodan, et al.
Publicado: (2023)

Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis
por: Wang, Jiabin, et al.
Publicado: (2022)

Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
por: Zhang, Shumei, et al.
Publicado: (2022)

Integrative analysis of DNA methylation and gene expression through machine learning identifies stomach cancer diagnostic and prognostic biomarkers
por: Hosseini, Maryam, et al.
Publicado: (2023)

Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
por: Wenger, Anna, et al.
Publicado: (2019)

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
por: Wang, Jiao, et al.
Publicado: (2020)

MicroRNA-141 is a tumor regulator and prognostic biomarker in human glioblastoma
por: Xiong, Xuehua, et al.
Publicado: (2017)

Biomarker-based prognostic stratification of young adult glioblastoma
por: Zhang, Rui-qi, et al.
Publicado: (2015)

Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma
por: Li, Mingdong, et al.
Publicado: (2019)

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
por: Lak, Nathalie S.M., et al.
Publicado: (2023)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

Gene expression and prognosis of sirtuin family members in ovarian cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

DNA CpG methylation in sequential glioblastoma specimens
por: Kraboth, Zoltan, et al.
Publicado: (2020)

Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
por: Mao, Xiao-hong, et al.
Publicado: (2021)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma
por: Tian, Yin, et al.
Publicado: (2023)

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma
por: Chen, Guang, et al.
Publicado: (2016)

The lipid peroxidation-derived DNA adduct γ-OHPdG as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Cao, Qiwei, et al.
Publicado: (2023)

Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma
por: Wang, Siqi, et al.
Publicado: (2019)

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
por: Massen, Maartje, et al.
Publicado: (2022)

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers
por: de Almeida, Bernardo P., et al.
Publicado: (2019)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma
por: Zhu, Yun, et al.
Publicado: (2019)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Prognostic value of DNA repair genes based on stratification of glioblastomas
por: Kun, Sun, et al.
Publicado: (2017)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
por: Kristensen, Lasse S., et al.
Publicado: (2016)

DNA methylation of Hugl‐2 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Miao, Yi, et al.
Publicado: (2020)

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma
por: Liu, Yutao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k1il7of446mt68rj4r4fv1uka1